Real-World data reveals how kidney cancer patients fare on modern immunotherapies
NCT ID NCT05858749
Summary
This study analyzed existing medical records to understand how well different immunotherapy combinations work for people with advanced kidney cancer that has spread. Researchers looked at data from 494 patients who received these modern treatments first, followed by other therapies. They compared how long treatments kept working, how patients responded, and overall survival to see which approaches might be most effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Headquarters
New York, New York, 10017, United States
Conditions
Explore the condition pages connected to this study.